What is the duration of citalopram (Celexa) withdrawal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duration of Citalopram (Celexa) Withdrawal

Citalopram (Celexa) withdrawal symptoms typically last 1-4 weeks, though in some cases they may persist for up to 3 months in sensitive individuals. 1

Withdrawal Timeline

The withdrawal process from citalopram follows a predictable pattern:

  • Onset: Symptoms usually begin within 24-48 hours after discontinuation
  • Peak intensity: Symptoms reach maximum severity around day 5
  • Resolution: Most symptoms resolve within 2-3 weeks 2
  • Extended cases: Some patients may experience symptoms for up to 4 weeks, and rarely longer 1

Common Withdrawal Symptoms

Citalopram withdrawal can manifest with various symptoms:

Neurological/Physical Symptoms

  • Dizziness and vertigo
  • Headache
  • Tremors
  • Paresthesia ("brain zaps")
  • Nausea and flu-like symptoms
  • Sleep disturbances

Psychological Symptoms

  • Anxiety and irritability
  • Confusion
  • Excessive dreaming
  • Insomnia
  • Mood fluctuations

Risk Factors for More Severe or Prolonged Withdrawal

Several factors can influence the severity and duration of citalopram withdrawal:

  • Medication half-life: Citalopram has a moderate half-life compared to other SSRIs, making it less likely to cause severe withdrawal than shorter-acting SSRIs like paroxetine 2
  • Duration of treatment: Longer treatment periods increase risk of withdrawal
  • Dosage: Higher doses correlate with more intense withdrawal symptoms
  • Discontinuation method: Abrupt discontinuation leads to more severe symptoms than gradual tapering
  • Individual factors: Previous history of withdrawal from other medications, concomitant medications, and alcohol use 2

Managing Citalopram Withdrawal

To minimize withdrawal symptoms and reduce their duration:

  1. Gradual tapering is essential:

    • Traditional guidelines recommend tapering over 2-4 weeks
    • However, evidence suggests that longer, more gradual tapers over months may be more successful in reducing withdrawal symptoms 3
    • Hyperbolic tapering (progressively smaller dose reductions) may be more effective than linear tapering 3
  2. For severe withdrawal symptoms:

    • Consider temporarily returning to the previous dose until stabilized
    • Resume tapering at a slower rate
    • In extreme cases, reintroducing the medication and starting a more gradual taper may be necessary 2
  3. Supportive care:

    • Educate patients about expected symptoms
    • Provide reassurance that symptoms are temporary
    • Consider non-pharmacological approaches for symptom management

Important Considerations

  • Withdrawal symptoms should not be confused with recurrence of depression, though distinguishing between them can be challenging
  • Withdrawal symptoms typically appear within days of dose reduction or discontinuation, while depression recurrence usually takes weeks to develop
  • The presence of distinctive physical symptoms (dizziness, paresthesia, nausea) suggests withdrawal rather than recurrence

Common Pitfalls to Avoid

  • Tapering too quickly: This is the most common mistake that prolongs withdrawal symptoms
  • Misinterpreting withdrawal as relapse: This can lead to unnecessary long-term medication continuation
  • Underestimating severity: Withdrawal can be severe and debilitating for some patients
  • Inadequate patient education: Patients should be informed about potential withdrawal symptoms before starting the medication

Remember that while most patients will experience resolution of withdrawal symptoms within 1-4 weeks, a minority may have more prolonged symptoms requiring additional support and an individualized approach to tapering.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Paroxetine withdrawal syndrome].

Annales de medecine interne, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.